Press release
Dry Age Macular Degeneration Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight
Dry Age Macular Degeneration Pipeline
Key Takeaways from the Dry AMD Market Research Report
• The total Dry Age Macular Degeneration prevalent cases in the 7MM was nearly 68,347,900 in 2023.
• Among the 7MM, the US accounted for the highest prevalent cases of dry AMD in 2023, with around 20,970,000 cases; these cases are expected to increase during the forecast period.
• The leading Dry Age Macular Degeneration Companies working in the market include Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
• Promising Dry Age Macular Degeneration Therapies in the various stages of development include Gildeuretinol (ALK-001), Tinlarebant (LBS-008), AVD-104, JNJ-1887, Luminate (risuteganib), OpRegen, CT1812, Elamipretide, EG-301, ANX007, NGM621, Danicopan (ALXN2040), IONIS-FB-LRx, Iptacopan (LNP023), CPCB-RPE1, and others.
• April 2024:- LumiThera Inc- This study is an open-label, prospective, multi-center extension study on the continued use of photobiomodulation (PBM) in subjects with dry age-related macular degeneration (AMD) that participated in the CSP005 LIGHTSITE III study.
• January 2024:- Pixium Vision SA- In this study, the principle functionality of the device will be tested in humans for the first time. The study will evaluate the extent to which patients with atrophic dry age related macular degeneration (AMD) have evoked light perception using the implant.
• January 2024:- Smilebioteck Zhuhai Limited- This is a phase 2, double-masked, randomized, placebo-controlled, dose-response study. The primary objective of the study is to evaluate the efficacy of QA102 oral capsules on the development of soft drusen, visual acuity (VA), and geographic atrophy (GA) or choroidal neovascularization (CNV) or the progression of GA in subjects with intermediate to advanced dry AMD.
Discover which therapies are expected to grab the Dry Age Macular Degeneration Market Share @ Dry Age Macular Degeneration Market Outlook- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Overview
Dry Age-Related Macular Degeneration (AMD) is a common eye condition that affects the macula, a small area in the center of the retina responsible for sharp, central vision. In this condition, the macula deteriorates over time, leading to gradual loss of central vision. "Dry" refers to the absence of abnormal blood vessel growth, which is characteristic of the wet form of AMD. Dry AMD typically progresses slowly and may result in blurred vision, difficulty seeing in low light, and eventual loss of central vision, though peripheral vision usually remains intact.
Dry Age Macular Degeneration Epidemiology Insights
The epidemiology section of Dry Age Macular Degeneration offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Dry Age Macular Degeneration Epidemiology trends @ Dry Age Macular Degeneration Epidemiological Insights- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Drugs Market
The Dry Age Macular Degeneration Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Dry Age Macular Degeneration signaling in Dry Age Macular Degeneration are likely to uncover new therapeutic targets and further expand treatment options for patients.
Dry Age Macular Degeneration Treatment Market Landscape
The Dry Age Macular Degeneration treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Dry Age Macular Degeneration has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Dry Age Macular Degeneration treatment guidelines, visit @ Dry Age Macular Degeneration Treatment Market Landscape- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Market Outlook
The report's outlook on the Dry Age Macular Degeneration market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Dry Age Macular Degeneration therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Dry Age Macular Degeneration drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Dry Age Macular Degeneration market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Dry Age Macular Degeneration Drugs Uptake
The drug chapter of the Dry Age Macular Degeneration report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Dry Age Macular Degeneration.
Major Dry Age Macular Degeneration Companies
Several Dry Age Macular Degeneration Companies working in the market include Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
Learn more about the FDA-approved drugs for Dry Age Macular Degeneration @ Drugs for Dry Age Macular Degeneration Treatment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Dry Age Macular Degeneration Market Report
• Coverage- 7MM
• Dry Age Macular Degeneration Companies- Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
• Dry Age Macular Degeneration Therapies- Gildeuretinol (ALK-001), Tinlarebant (LBS-008), AVD-104, JNJ-1887, Luminate (risuteganib), OpRegen, CT1812, Elamipretide, EG-301, ANX007, NGM621, Danicopan (ALXN2040), IONIS-FB-LRx, Iptacopan (LNP023), CPCB-RPE1, and others.
• Dry Age Macular Degeneration Market Dynamics: Dry Age Macular Degeneration Market Drivers and Barriers
• Dry Age Macular Degeneration Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Dry Age Macular Degeneration Drugs in development @ Dry Age Macular Degeneration Clinical Trials Assessment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Executive Summary of Dry AMD
4. Key Events
5. Epidemiology and Market Forecast Methodology
6. Dry AMD Market Overview at a Glance
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
9.1. Description
10. Marketed Drugs
11. Emerging Drugs
12. Dry AMD: Market Analysis
13. Unmet Needs
14. SWOT Analysis
15. KOL Views
16. Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website:- https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age Macular Degeneration Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight here
News-ID: 3482539 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Dry
Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market …
The Dry Eye Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dry Eye Products Market Size During the Forecast Period?
In recent years, there has been a significant expansion in the market size of dry eye products. The market is projected…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Dry Eye Market - Advancing Eye Wellness: Dry Eye Solutions Revolutionizing Relie …
Newark, New Castle, USA - new report, titled Dry Eye Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Dry Eye market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Dry Eye market. The report offers an overview of the market, which…
Dry Lubricants Market Size to Hit $ 813.78 Million by 2028 | Dry Lubricants Indu …
According to our experience research team, Dry Lubricants Market was valued at USD 755.42 Million in 2021, and the global Dry Lubricants industry is projected to reach a value of USD 813.78 Million by 2028, at a CAGR of 1.2% during the forecast period 2022-2028
The report is focused on gaining various Dry Lubricants market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
Dry Screw Vacuum Pumps
Swam Dry vacuum pumps are the latest development in the vacuum pump industry. They offer a number of advantages over traditional vacuum pump designs. Best process gas blowers. There is “NO OIL / NO WATER” contact with the process vapours, which is why they are considered extremely environmentally friendly.
Visit us for more info - http://swamatics.com/ProductDetails.aspx?prod=Process%20Gas%20Blowers/Gas%20Boosters
The definition of a dry vacuum pump is a pump that does not use any…
